Capstone Investment Advisors’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-121
Closed -$32K 497
2020
Q1
$32K Sell
121
-2,534
-95% -$670K ﹤0.01% 275
2019
Q4
$860K Buy
2,655
+1,051
+66% +$340K ﹤0.01% 257
2019
Q3
$438K Buy
1,604
+760
+90% +$208K ﹤0.01% 255
2019
Q2
$451K Sell
844
-97
-10% -$51.8K ﹤0.01% 311
2019
Q1
$474K Buy
941
+550
+141% +$277K ﹤0.01% 232
2018
Q4
$193K Buy
391
+135
+53% +$66.6K ﹤0.01% 281
2018
Q3
$234K Buy
+256
New +$234K ﹤0.01% 292
2018
Q1
Sell
-440
Closed -$394K 346
2017
Q4
$394K Buy
+440
New +$394K 0.01% 225